Skip to content

Pennsylvania Medical Marijuana Program, What To Know

January 6, 2022

In 2016, Pennsylvania adopted Act 16, becoming one of 38 states that have medical marijuana programs in the United States. The Pennsylvania Department of Health regulates licensing and has issued 25 grower/processor licenses and fifty dispensary licenses to date. Aiming to be a pioneer in cannabis research, in 2018 Pennsylvania made provisions for eight Academic Clinical Research Center permits to be granted to accredited medical schools that have a relationship with an acute care hospital. This permit allows for an additional grower/processor permit to conduct clinical research relating to medical marijuana. So far, some of the state’s best-known medical schools have been certified by the Pennsylvania Department of Health. Their research focuses on medical conditions such as the treatment of neuropathies, autism, opioid dependence, and sickle cell disease. In May of 2021, Temple University researchers discovered a new CBD derivative KLS-13019 that could be used to treat peripheral neuropathy associated with some cancer treatments.

Effects of COVID-19 on the cannabis space

The rules that govern the cannabis industry in Pennsylvania were loosened during the pandemic. Dispensaries were declared essential businesses and patients were given access to telemedicine consultations to obtain medical marijuana user cards. As an example, one of the more significant rule changes permitted curbside pick-up at dispensaries. The number of registered caregivers was expanded significantly, and home delivery of cannabis was approved. Many dispensaries implemented apps that optimized delivery routes. These temporary pandemic rules were codified under Act 44 and signed into law by Governor Wolf in the summer of 2021. The fact that the industry quickly pivoted to provide essential services in unchartered waters is telling of a healthy business environment. Cannabis sales topped $600 million in 2020 and they are expected to pass the $1 billion mark by 2023.

While COVID fast-tracked certain aspects of the PA cannabis industry, major hurdles, like access to proper banking services, still plague operators in the space. The services of the financial institution come with an increased cost and some growers report being charged an exorbitant amount in monthly fees. Banks justify these fees as a cost of compliance and due diligence, such as filing suspicious activity reports and processing cash-heavy deposits and withdrawals. Community-oriented institutions that do not charge extra fees are difficult to find.

Legalization in the future

In November of 2021, Philadelphia voters passed a resolution calling on the Pennsylvania General Assembly and Governor Wolf to implement adult-use legislation in the state. The will of the voters of the state’s largest city echoed increased calls for statewide legalization by the legislators over the course of the pandemic. In September of 2021, Representatives Wheatley and Frankel introduced House Bill 2050 that authorizes adults 21 years or older to purchase and possess up to an ounce of cannabis along with home cultivation of three mature and three immature plants. All purchases are subject to a 13% excise tax with a part of the proceeds dedicated to community reinvestment. Pennsylvania Departments of Revenue, Agriculture, Health, and the attorney general’s office will be tasked with industry regulation.

A bipartisan Street-Laughlin Senate Bill 473 introduced in October of 2021 similarly authorizes purchasing from a licensed dispensary and possession of up to 30 grams of cannabis for adults. Medical marijuana patients are permitted to cultivate up to five plants at home. This bill is significant because it garnered Republican support in what has been a largely Democratic effort to legalize.  S.B. 473 also engages the agricultural sectors by providing cultivation licenses. This legislation proposes the establishment of a Cannabis Regulatory Board that would regulate the business establishment, marketing, packing, and labeling.  Both H.B. 2050 and S.B. 473 account for social and economic equity by earmarking new licenses to historically disadvantaged individuals and expunging non-violent marijuana convictions.

In a separate effort, a GOP lawmaker Mike Regan with a background in federal law enforcement announced a plan to introduce legislation that would largely legalize recreational marijuana, establish a new regulatory board, and address social equity and assistance for business entry into the industry. Governor Wolf has been very receptive to these legalization efforts. Perhaps a sign of increased acceptance of the cannabis space, the Pittsburgh area welcomed its first drive-through medical cannabis dispensary in the summer of 2021.

The views and opinions expressed in the article represent the view of the author and not necessarily the official view of Clark Hill PLC. Nothing in this article constitutes professional legal advice nor is intended to be a substitute for professional legal advice.

Subscribe For The Latest

Subscribe

Related

Event

Webinar: Stay Ahead in Privacy and Data Breach Litigation

Join us for an essential update on the dynamic landscape of privacy and data breach litigation. This session will explore the latest trends and emerging challenges, including developments in Pixel litigation, BIPA, GIPA, CIPA, VPPA, standing issues, and critical defense strategies. We’ll analyze recent cases, pivotal rulings, and newly filed lawsuits while providing strategic guidance for litigation and settlement. Gain actionable insights to help you confidently navigate this complex and evolving legal environment confidently.

Don’t miss this opportunity to stay informed and prepared in the evolving field of privacy and data breach litigation.

Explore more
Event

Webinar- Digital Operational Resilience Act (DORA): A Cross-Border Discussion on Incident Response

Join us for an in-depth discussion on how the Digital Operational Resilience Act (DORA), effective January 17, 2025, will transform digital and operational resilience requirements in the financial sector. This session will focus on the specific obligations related to incident response and explore the adjustments businesses should make to their existing programs to achieve compliance.

Explore more
Event

Webinar: AI Year in Review: From State AI Laws and Automated Decision-Making Regulations to the Rise of AI Liability

2024 has been a pivotal year for artificial intelligence, marked by the passage of state AI legislation, the introduction of privacy regulations targeting automated decision-making and profiling, and an uptick in lawsuits challenging businesses’ use of AI tools. This webinar will provide a comprehensive review of the evolving AI landscape, summarizing key enacted laws, exploring emerging legal challenges, and offering actionable strategies for businesses deploying AI technologies.

Explore more